journal article·2013-08Open access

Novel Nanodimension artificial red blood cells that act as O 2 and CO 2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase

Wei Gao, Yuzhu Bian, Thomas M.S. Chang

Abstract

Poly(ethylene glycol)-Poly(lactic acid) block-copolymer (PEG-PLA) was prepared and characterized using Fourier transform infrared spectrophotometer (FTIR). Glutaraldehyde was used to crosslink stroma-free hemoglobin (SFHb), superoxide dismutase (SOD), catalase (CAT), and carbonic anhydrase (CA) into a soluble complex of PolySFHb-SOD-CAT-CA. PEG-PLA was then used to nanoencapsulated PolySFHb-SOD-CAT-CA by oil in water emulsification. This resulted in the formation of PLA-PEG-PolySFHb-SOD-CAT-CA nanocapsules that have enhanced antioxidant activity and that can transport both O2 and CO2. These are homogeneous particles with an average diameter of 100 nm with good dispersion and core shell structure, high entrapment efficiency (EE%), and nanocapsule percent recovery. A lethal hemorrhagic shock model in rats was used to evaluate the therapeutic effect of the PLA-PEG-PolySFHb-SOD-CAT-CA nanocapsules. Infusion of this preparation resulted in the lowering of the elevated tissue PCO2 and also recovery of the mean arterial pressure (MAP).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Nitric Oxide and Endothelin Effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, Artificial Cells and Organs Research Center, McGill University

Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University

References (28)

Show source-provided references
1. 10.1038/nrd130710.1038/nrd1307 ↗
2. 10.3109/10731199.2011.58105210.3109/10731199.2011.581052 ↗
3. 10.3109/10731199.2013.74529110.3109/10731199.2013.745291 ↗
4. 10.3109/1073119950911797710.3109/10731199509117977 ↗
5. 10.1016/j.freeradbiomed.2004.04.00810.1016/j.freeradbiomed.2004.04.008 ↗
6. 10.1097/SHK.0b013e31817c0eb710.1097/SHK.0b013e31817c0eb7 ↗
7. 10.1126/science.146.3643.52410.1126/science.146.3643.524 ↗
8. 10.1016/S0006-291X(71)80260-710.1016/S0006-291X(71)80260-7 ↗
9. Chang TMS, Powanda D, Yu WP. 2003. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Biotechnology. 31:231–247.
10. 10.1038/nrd165910.1038/nrd1659 ↗
11. Chang TMS. 2007. Artificial Cells: Biotechnology Nanomedicine Regenerative Medicine Blood Substitutes Bioencapsulation Cell/Stem Cell Therapy. Singapore/London: World Scientific/ Imperial College.10.1142/6395 ↗
12. 10.1016/j.transproceed.2004.08.14610.1016/j.transproceed.2004.08.146 ↗
13. 10.1038/nbt0798-66710.1038/nbt0798-667 ↗
14. 10.1152/physrev.2000.80.2.68110.1152/physrev.2000.80.2.681 ↗
15. Djordjevich L, Miller IF. 1980. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol. 8:584–592.
16. Fustier C, Chang TMS. 2012. PEG-PLA nanocapsules containing a nanobiotechnological complex of polyhemoglobin-tyrosinase for the depletion of tyrosine in melanoma: preparation and in vitro characterisation. Nanomedicine Biotherapeu Discover. 2:1–6.
17. 10.1016/j.biomaterials.2011.08.04610.1016/j.biomaterials.2011.08.046 ↗
18. 10.1097/TA.0b013e318173a93f10.1097/TA.0b013e318173a93f ↗
19. Luo W, Li S, Bei J, Wang S. 2002. Synthesis and characterization of poly ( L-lactide ) - poly ( ethylene glycol ) multiblock copolymers. Polymer. 84:1729–1736.
20. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA multicenter trial. Shock. 208:1–13.
21. 10.1016/j.bbapap.2008.03.01310.1016/j.bbapap.2008.03.013 ↗
22. 10.1081/BIO-12000272510.1081/BIO-120002725 ↗
23. 10.1021/bc800431d10.1021/bc800431d ↗
24. Winslow RM. Ed. 2006. Blood Substitutes. Amsterdam: Academic Press.
25. 10.1161/CIRCULATIONAHA.107.72913710.1161/CIRCULATIONAHA.107.729137 ↗
26. 10.3109/1073119940911792610.3109/10731199409117926 ↗
27. 10.1007/s10856-008-3676-y10.1007/s10856-008-3676-y ↗
28. 10.3109/1073119100363423210.3109/10731191003634232 ↗